Guidelines for radioiodine therapy of differentiated thyroid cancer

@article{Luster2008GuidelinesFR,
  title={Guidelines for radioiodine therapy of differentiated thyroid cancer},
  author={Markus Luster and Susan E. M. Clarke and Markus Dietlein and Michael Lassmann and Peter Lind and Wim J. G. Oyen and Jan G Tennvall and Emilio Bombardieri},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2008},
  volume={35},
  pages={1941-1959}
}
The purpose of the present guidelines on the radioiodine therapy (RAIT) of differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear Medicine (EANM) Therapy Committee is to provide advice to nuclear medicine clinicians and other members of the DTC-treating community on how to ablate thyroid remnant or treat inoperable advanced DTC or both employing large 131-iodine (131I) activities. For this purpose, recommendations have been formulated based on recent literature… CONTINUE READING
Highly Influential
This paper has highly influenced 16 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 168 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 130 references

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy

  • C Durante
  • J Clin Endocrinol Metab
  • 2006
Highly Influential
20 Excerpts

Similar Papers

Loading similar papers…